LABP

Landos Biopharma (LABP)

Landos Biopharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:LABP

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/03	19 : 04	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:LABP	Landos Biopharma Inc
2024/05/24	06 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LABP	Landos Biopharma Inc
2024/05/24	06 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LABP	Landos Biopharma Inc
2024/05/24	06 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LABP	Landos Biopharma Inc
2024/05/24	06 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LABP	Landos Biopharma Inc
2024/05/24	06 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LABP	Landos Biopharma Inc
2024/05/24	05 : 52	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:LABP	Landos Biopharma Inc
2024/05/24	05 : 49	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:LABP	Landos Biopharma Inc
2024/05/24	05 : 48	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:LABP	Landos Biopharma Inc
2024/05/24	05 : 47	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:LABP	Landos Biopharma Inc
2024/05/24	05 : 46	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:LABP	Landos Biopharma Inc
2024/05/24	05 : 29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LABP	Landos Biopharma Inc
2024/05/24	05 : 05	PR Newswire (US)	AbbVie Completes Acquisition of Landos Biopharma	NASDAQ:LABP	Landos Biopharma Inc
2024/05/24	01 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LABP	Landos Biopharma Inc
2024/05/09	21 : 32	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LABP	Landos Biopharma Inc
2024/03/25	21 : 31	PR Newswire (US)	AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases	NASDAQ:LABP	Landos Biopharma Inc
2024/03/25	21 : 30	GlobeNewswire Inc.	AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases	NASDAQ:LABP	Landos Biopharma Inc
2024/03/05	06 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LABP	Landos Biopharma Inc
2024/03/05	06 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LABP	Landos Biopharma Inc
2024/02/15	06 : 01	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:LABP	Landos Biopharma Inc
2024/01/04	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LABP	Landos Biopharma Inc
2023/11/21	22 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LABP	Landos Biopharma Inc
2023/11/09	22 : 22	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LABP	Landos Biopharma Inc
2023/11/09	22 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LABP	Landos Biopharma Inc
2023/09/21	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LABP	Landos Biopharma Inc
2023/09/14	21 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LABP	Landos Biopharma Inc
2023/08/09	21 : 18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LABP	Landos Biopharma Inc
2023/08/09	21 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LABP	Landos Biopharma Inc
2023/06/02	05 : 20	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:LABP	Landos Biopharma Inc
2023/05/26	05 : 20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:LABP	Landos Biopharma Inc